PL1499278T3 - Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon - Google Patents

Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Info

Publication number: PL1499278T3
Authority: PL; Poland
Prior art keywords: dosage form; immediate; pharmaceutical dosage; release pharmaceutical; polymorphous tibolone
Prior art date: 2003-05-23

Application number

PL04737220T

Other languages

English (en)

Inventor

Haan Pieter N V Organon De

Original Assignee

Msd Oss Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-23

Filing date

2004-05-19

Publication date

2005-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1499278(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-05-19 Application filed by Msd Oss Bv filed Critical Msd Oss Bv

2005-09-30 Publication of PL1499278T3 publication Critical patent/PL1499278T3/pl

Links

239000002552 dosage form Substances 0.000 title abstract 3
WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title abstract 3
229960001023 tibolone Drugs 0.000 title abstract 3
239000012729 immediate-release (IR) formulation Substances 0.000 title abstract 2
239000013543 active substance Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL04737220T 2003-05-23 2004-05-19 Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon PL1499278T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03101500		2003-05-23
EP04737220A EP1499278B1 (en)	2003-05-23	2004-05-19	Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
PCT/EP2004/050852 WO2004103378A1 (en)	2003-05-23	2004-05-19	Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Publications (1)

Publication Number	Publication Date
PL1499278T3 true PL1499278T3 (pl)	2005-09-30

Family

ID=33442854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04737220T PL1499278T3 (pl)	2003-05-23	2004-05-19	Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Country Status (16)

Country	Link
US (1)	US20060134191A1 (pl)
EP (1)	EP1499278B1 (pl)
JP (1)	JP2006514996A (pl)
KR (2)	KR20050038590A (pl)
AT (1)	ATE296606T1 (pl)
AU (1)	AU2004203420B8 (pl)
CA (1)	CA2473718A1 (pl)
DE (1)	DE602004000016T2 (pl)
DK (1)	DK1499278T3 (pl)
ES (1)	ES2243919T3 (pl)
MX (1)	MXPA05000824A (pl)
NZ (1)	NZ534446A (pl)
PL (1)	PL1499278T3 (pl)
PT (1)	PT1499278E (pl)
WO (1)	WO2004103378A1 (pl)
ZA (1)	ZA200406042B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1563833B1 (de) *	2004-02-06	2006-11-02	Helm AG	Pharmazeutische Zubereitungen mit amorphem Tibolon
AU2008317307A1 (en) *	2007-10-25	2009-04-30	Novartis Ag	Powder conditioning of unit dose drug packages
KR101361244B1 (ko) *	2012-02-23	2014-02-11	박현석	무선 메시지를 이용한 문서 전송 시스템 및 방법
CN107078529A (zh) *	2015-11-02	2017-08-18	约瑟夫·古德里奇	可充电式照明鞋子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE665514A (pl) *	1964-06-16
FR2408345A1 (fr) *	1976-11-30	1979-06-08	Besins Jean Louis	Nouvelle composition a action anti-conceptionnelle
US4701450A (en) *	1984-03-21	1987-10-20	Akzo N.V.	Steroids for use as immunomodulators
IE63051B1 (en) *	1989-03-18	1995-03-22	Akzo Nv	Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) *	1997-04-22	2004-09-27	Akzo Nobel Nv	Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US6761903B2 (en) *	1999-06-30	2004-07-13	Lipocine, Inc.	Clear oil-containing pharmaceutical compositions containing a therapeutic agent
BR0108107A (pt) *	2000-01-28	2003-03-11	Endorech Inc	Moduladores seletivos dos receptores de estrogênio em combinação com estrogênios; kits e composições farmacêuticas para praticar tal combinação; bem como a administração da referida combinação
ATE364619T1 (de) *	2001-10-18	2007-07-15	Norton Healthcare Ltd	Tibolonformulierungen

2004
- 2004-05-19 MX MXPA05000824A patent/MXPA05000824A/es active IP Right Grant
- 2004-05-19 US US10/503,356 patent/US20060134191A1/en not_active Abandoned
- 2004-05-19 JP JP2005518190A patent/JP2006514996A/ja active Pending
- 2004-05-19 KR KR1020047012310A patent/KR20050038590A/ko not_active Ceased
- 2004-05-19 ES ES04737220T patent/ES2243919T3/es not_active Expired - Lifetime
- 2004-05-19 WO PCT/EP2004/050852 patent/WO2004103378A1/en not_active Ceased
- 2004-05-19 PT PT04737220T patent/PT1499278E/pt unknown
- 2004-05-19 DK DK04737220T patent/DK1499278T3/da active
- 2004-05-19 PL PL04737220T patent/PL1499278T3/pl unknown
- 2004-05-19 DE DE602004000016T patent/DE602004000016T2/de not_active Expired - Lifetime
- 2004-05-19 AT AT04737220T patent/ATE296606T1/de active IP Right Revival
- 2004-05-19 KR KR1020067003455A patent/KR20060028822A/ko not_active Ceased
- 2004-05-19 EP EP04737220A patent/EP1499278B1/en not_active Revoked
- 2004-05-19 NZ NZ534446A patent/NZ534446A/en unknown
- 2004-05-19 CA CA002473718A patent/CA2473718A1/en active Granted
- 2004-05-19 AU AU2004203420A patent/AU2004203420B8/en not_active Expired
- 2004-07-28 ZA ZA200406042A patent/ZA200406042B/en unknown

Also Published As

Publication number	Publication date
EP1499278B1 (en)	2005-06-01
AU2004203420B2 (en)	2008-01-31
MXPA05000824A (es)	2005-04-28
DE602004000016T2 (de)	2005-11-03
ATE296606T1 (de)	2005-06-15
US20060134191A1 (en)	2006-06-22
PT1499278E (pt)	2005-08-31
JP2006514996A (ja)	2006-05-18
NZ534446A (en)	2007-03-30
EP1499278A1 (en)	2005-01-26
DK1499278T3 (da)	2005-10-03
ES2243919T3 (es)	2005-12-01
KR20060028822A (ko)	2006-04-03
ZA200406042B (en)	2006-05-31
KR20050038590A (ko)	2005-04-27
WO2004103378A1 (en)	2004-12-02
DE602004000016D1 (de)	2005-07-07
CA2473718A1 (en)	2004-11-23
AU2004203420A1 (en)	2004-12-02
AU2004203420B8 (en)	2008-02-21

Publication	Publication Date	Title
AU2003274681A1 (en)	2004-02-23	Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
GEP20074047B (en)	2007-02-26	Pramipexole once-daily dosage form
DK0954314T3 (da)	2002-02-18	Doseringsformer til bedring af mandlig erektionsdefekt
TW200505498A (en)	2005-02-16	Sugar-free oral transmucosal solid dosage forms and uses thereof
MX2007015480A (es)	2008-04-29	Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
BG108516A (en)	2004-12-30	Pharmaceutical formulation
IL165786A0 (en)	2006-01-15	Ibuprofen suspension
IL150528A0 (en)	2003-02-12	Ibuprofen containing active agent preparation
ATE287264T1 (de)	2005-02-15	Oral anzuwendende buprenorphinhaltige arzneimittel
BR0112847A (pt)	2003-06-24	Uso de uma forma de dosagem sólida
MXPA03008420A (es)	2004-03-16	Forma farmaceutica solida oralmente dispersa.
MXPA06000332A (es)	2006-03-30	Nueva composicion farmaceutica solida que comprende amisulprida.
PL1499278T3 (pl)	2005-09-30	Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
MY130445A (en)	2007-06-29	Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
ATE297760T1 (de)	2005-07-15	Pharmazeutische zusammensetzungen enthaltend terbinafin
PL378106A1 (pl)	2006-03-06	Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
MY141008A (en)	2010-02-12	Oral formulations of deoxypeganine and their uses
DE60211916D1 (de)	2006-07-06	Synergistische füllzusammensetzung
WO2007119249A3 (en)	2008-05-22	Pharmaceutical compositions of cefixime
TW200621304A (en)	2006-07-01	Pharmaceutical composition
TW200621224A (en)	2006-07-01	Pharmaceutical composition
WO2005115092A3 (en)	2006-03-23	Micronized oral pharmaceutical composition
IL162769A0 (en)	2005-11-20	Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
HK1070286A (en)	2005-06-17	Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
ECSP982396A (es)	1999-01-12	Composiciones que contienen tetrahidrolipstatina